Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction

AIMS: Ivabradine and sacubitril/valsartan are second‐line therapies for patients with heart failure and reduced ejection fraction (HFrEF) based on guideline recommendations. We aimed to evaluate the synergistic effects of these two medications. METHODS AND RESULTS: Patients' data were extracted...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:ESC Heart Fail
मुख्य लेखकों: Lee, Ying‐Hsiang, Lin, Po‐Lin, Chiou, Wei‐Ru, Huang, Jin‐Long, Lin, Wen‐Yu, Liao, Chia‐Te, Chung, Fa‐Po, Liang, Huai‐Wen, Hsu, Chien‐Yi, Chang, Hung‐Yu
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2021
विषय:
Original Research Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006660/
https://ncbi.nlm.nih.gov/pubmed/33410280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13182
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन